The 2020 figure represents a 55% year-on-year surge in funding in digital health, medical devices, biotech and pharma firms, IATI says; M&A deals plunge
Texas's Cancer Focus Fund will support a Phase 1/2 clinical study assessing Israeli company's flagship drug, which uses 2 proteins - 1 to mark cancer cells and 1 to weaken them
Recent comments